<DOC>
	<DOCNO>NCT00418314</DOCNO>
	<brief_summary>The objective study demonstrate frequent atrio-ventricular ( AV/PV ) inter-ventricular ( V-V ) delay optimization use QuickOpt patient cardiac resynchronization therapy device result improve clinical response standard care ( i.e . empiric program one-time optimization use non-intracardiac electrogram optimization method ) .</brief_summary>
	<brief_title>FREEDOM - A Frequent Optimization Study Using QuickOpt Method</brief_title>
	<detailed_description>- This prospective , double-blinded , multicenter , randomize study - Patient could enrol 2 week post CRT-D implant follow 12 month post implant follow-up visit 3 , 6 , 9 12 month - Patients randomize enrollment either Group 1 ( `` QuickOpt Group '' ) Group 2 ( `` Control Group '' ) . - Group 1 - The patient 's device program sequential biventricular pacing mode AV/PV VV delay optimize use QuickOpt . For Group 1 patient , optimization use QuickOpt perform enrollment , 3 month , 6 month , 9 month , 12 month unscheduled follow-up visit . - Group 2 - The patient 's device program either simultaneous sequential BiV pace mode per physician 's discretion . The AV/PV inter-ventricular ( VV ) delay could program empirically optimize use non-IEGM base method per sit standard care . However , Group 2 patient optimize within first 4 week post implant . Any AV/PV VV delay optimization perform 4 week post implant Group 2 patient consider protocol deviation .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>Patient meet current CRTD indication implant St. Jude Medical ( SJM ) CRT¬D device VV timing compatible lead system . Patient ability complete 6minute hall walk limit factor fatigue shortness breath . Patient ability independently comprehend complete QOL questionnaire . Patient epicardial ventricular lead system . Patient ability walk ≥ 450 meter 6 minute Patient limit intrinsic atrial activity ( ≤ 40 bpm ) . Patient persistent permanent atrial fibrillation ( AF ) . Patient 2° 3° heart block . Patient 's life expectancy le 1 year . Patient pregnant . Patient IV inotropic agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>